Amyloid-β pathology and cerebral amyloid angiopathy are frequent in iatrogenic Creutzfeldt-Jakob disease after dural grafting.
- Frontzek K Institute of Neuropathology, University Hospital Zurich, Switzerland.
- Lutz MI Institute of Neurology, Medical University Vienna, Austria.
- Aguzzi A Institute of Neuropathology, University Hospital Zurich, Switzerland.
- Kovacs GG Institute of Neurology, Medical University Vienna, Austria.
- Budka H Institute of Neuropathology, University Hospital Zurich, Switzerland; Institute of Neurology, Medical University Vienna, Austria.
- 2016-01-27
Published in:
- Swiss medical weekly. - 2016
Adult
Aged
Aged, 80 and over
Amyloid beta-Peptides
Brain
Case-Control Studies
Cerebral Amyloid Angiopathy
Creutzfeldt-Jakob Syndrome
Dura Mater
Female
Humans
Iatrogenic Disease
Immunohistochemistry
Male
Middle Aged
Plaque, Amyloid
Tissue Transplantation
English
QUESTIONS UNDER STUDY
Alzheimer-type amyloid-β (Aβ) pathology was reported in brains of individuals developing iatrogenic Creutzfeldt-Jakob disease (iCJD) after treatment with human cadaveric growth hormone, and interpreted as evidence of human transmission of Aβ by the treatment. Here we investigated the prevalence of Aβ pathology in other instances of iCJD related to dura mater grafts.
METHODS
By use of immunohistochemistry for Aβ, we investigated seven brains of patients (age range 28-63) who succumbed to iCJD after dural grafting, which had been applied by means of neurosurgery between 11 and 25 years before death. For control, we examined a series of 21 brains of age-matched (40-63 years) patients with sporadic CJD (sCJD) and an additional series of 81 sCJD cases (55-85 years) with the same methods.
RESULTS
In five of seven iCJD brains, Aβ was deposited in meningeal vessels as congophilic amyloid angiopathy and brain parenchymal plaques. This was significantly (p <0.001) more frequent than in the age-matched sCJD controls and in the usual sCJD series.
CONCLUSIONS
We conclude that congophilic amyloid angiopathy and brain parenchymal Aβ plaques are frequent in iCJD after dural grafting. The presence of Aβ pathology in young individuals is highly unusual and suggests a causal relationship to the dural grafts. Further studies will be needed to elucidate whether such pathology resulted from the seeding of Aβ aggregates from the grafts to host tissues.
Alzheimer-type amyloid-β (Aβ) pathology was reported in brains of individuals developing iatrogenic Creutzfeldt-Jakob disease (iCJD) after treatment with human cadaveric growth hormone, and interpreted as evidence of human transmission of Aβ by the treatment. Here we investigated the prevalence of Aβ pathology in other instances of iCJD related to dura mater grafts.
METHODS
By use of immunohistochemistry for Aβ, we investigated seven brains of patients (age range 28-63) who succumbed to iCJD after dural grafting, which had been applied by means of neurosurgery between 11 and 25 years before death. For control, we examined a series of 21 brains of age-matched (40-63 years) patients with sporadic CJD (sCJD) and an additional series of 81 sCJD cases (55-85 years) with the same methods.
RESULTS
In five of seven iCJD brains, Aβ was deposited in meningeal vessels as congophilic amyloid angiopathy and brain parenchymal plaques. This was significantly (p <0.001) more frequent than in the age-matched sCJD controls and in the usual sCJD series.
CONCLUSIONS
We conclude that congophilic amyloid angiopathy and brain parenchymal Aβ plaques are frequent in iCJD after dural grafting. The presence of Aβ pathology in young individuals is highly unusual and suggests a causal relationship to the dural grafts. Further studies will be needed to elucidate whether such pathology resulted from the seeding of Aβ aggregates from the grafts to host tissues.
- Language
-
- English
- Open access status
- gold
- Identifiers
-
- DOI 10.4414/smw.2016.14287
- PMID 26812492
- Persistent URL
- https://sonar.ch/global/documents/161142
Statistics
Document views: 50
File downloads:
- Full-text: 0